Click for best price
Human Papillomavirus Vaccine 16 18 Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Human Papillomavirus Vaccine (Types 16, 18), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papillomavirus Vaccine (Types 16, 18). This report contains market size and forecasts of Human Papillomavirus Vaccine (Types 16, 18) in global, including the following market information:
Global Human Papillomavirus Vaccine (Types 16, 18) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Human Papillomavirus Vaccine (Types 16, 18) Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Human Papillomavirus Vaccine (Types 16, 18) companies in 2022 (%)
The global Human Papillomavirus Vaccine (Types 16, 18) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
HPV16 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Papillomavirus Vaccine (Types 16, 18) include GlaxoSmithKline, Merck & Co., Inc., Serum Institute of India, INNOVAX, ZSSW, HUMANWELL HEALTHCARE and WALVAX, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Human Papillomavirus Vaccine (Types 16, 18) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Papillomavirus Vaccine (Types 16, 18) Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Papillomavirus Vaccine (Types 16, 18) Market Segment Percentages, by Type, 2022 (%)
HPV16
HPV18
Global Human Papillomavirus Vaccine (Types 16, 18) Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Papillomavirus Vaccine (Types 16, 18) Market Segment Percentages, by Application, 2022 (%)
9-26 Years Old
26-45 Years Old
Global Human Papillomavirus Vaccine (Types 16, 18) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Human Papillomavirus Vaccine (Types 16, 18) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Papillomavirus Vaccine (Types 16, 18) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Papillomavirus Vaccine (Types 16, 18) revenues share in global market, 2022 (%)
Key companies Human Papillomavirus Vaccine (Types 16, 18) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Papillomavirus Vaccine (Types 16, 18) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck & Co., Inc.
Serum Institute of India
INNOVAX
ZSSW
HUMANWELL HEALTHCARE
WALVAX
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Papillomavirus Vaccine (Types 16, 18), market overview.
Chapter 2: Global Human Papillomavirus Vaccine (Types 16, 18) market size in revenue and volume.
Chapter 3: Detailed analysis of Human Papillomavirus Vaccine (Types 16, 18) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Papillomavirus Vaccine (Types 16, 18) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Papillomavirus Vaccine (Types 16, 18) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Papillomavirus Vaccine (Types 16, 18) Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Papillomavirus Vaccine (Types 16, 18) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Papillomavirus Vaccine (Types 16, 18) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Papillomavirus Vaccine (Types 16, 18) Overall Market Size
2.1 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size: 2022 VS 2032
2.2 Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Human Papillomavirus Vaccine (Types 16, 18) Sales: 2018-2032
3 Company Landscape
3.1 Top Human Papillomavirus Vaccine (Types 16, 18) Players in Global Market
3.2 Top Global Human Papillomavirus Vaccine (Types 16, 18) Companies Ranked by Revenue
3.3 Global Human Papillomavirus Vaccine (Types 16, 18) Revenue by Companies
3.4 Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Companies
3.5 Global Human Papillomavirus Vaccine (Types 16, 18) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Papillomavirus Vaccine (Types 16, 18) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Papillomavirus Vaccine (Types 16, 18) Players in Global Market
3.8.1 List of Global Tier 1 Human Papillomavirus Vaccine (Types 16, 18) Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Papillomavirus Vaccine (Types 16, 18) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Market Size Markets, 2022 & 2032
4.1.2 HPV16
4.1.3 HPV18
4.2 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue & Forecasts
4.2.1 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2023
4.2.2 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2024-2032
4.2.3 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
4.3 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales & Forecasts
4.3.1 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2023
4.3.2 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2024-2032
4.3.3 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
4.4 By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2022 & 2032
5.1.2 9-26 Years Old
5.1.3 26-45 Years Old
5.2 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue & Forecasts
5.2.1 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2023
5.2.2 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2024-2032
5.2.3 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
5.3 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales & Forecasts
5.3.1 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2023
5.3.2 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2024-2032
5.3.3 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
5.4 By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2022 & 2032
6.2 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue & Forecasts
6.2.1 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2023
6.2.2 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2024-2032
6.2.3 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
6.3 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales & Forecasts
6.3.1 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2023
6.3.2 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales, 2024-2032
6.3.3 By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032
6.4.2 By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2032
6.4.3 US Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.4.4 Canada Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.4.5 Mexico Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032
6.5.2 By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2032
6.5.3 Germany Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.4 France Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.5 U.K. Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.6 Italy Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.7 Russia Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.8 Nordic Countries Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.5.9 Benelux Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032
6.6.2 By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2032
6.6.3 China Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.6.4 Japan Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.6.5 South Korea Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.6.6 Southeast Asia Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.6.7 India Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032
6.7.2 By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2032
6.7.3 Brazil Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.7.4 Argentina Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Sales, 2018-2032
6.8.3 Turkey Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.8.4 Israel Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.8.5 Saudi Arabia Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
6.8.6 UAE Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.1.4 GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.2.4 Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co., Inc. Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.3.4 Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 INNOVAX
7.4.1 INNOVAX Company Summary
7.4.2 INNOVAX Business Overview
7.4.3 INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.4.4 INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.4.5 INNOVAX Key News & Latest Developments
7.5 ZSSW
7.5.1 ZSSW Company Summary
7.5.2 ZSSW Business Overview
7.5.3 ZSSW Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.5.4 ZSSW Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.5.5 ZSSW Key News & Latest Developments
7.6 HUMANWELL HEALTHCARE
7.6.1 HUMANWELL HEALTHCARE Company Summary
7.6.2 HUMANWELL HEALTHCARE Business Overview
7.6.3 HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.6.4 HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.6.5 HUMANWELL HEALTHCARE Key News & Latest Developments
7.7 WALVAX
7.7.1 WALVAX Company Summary
7.7.2 WALVAX Business Overview
7.7.3 WALVAX Human Papillomavirus Vaccine (Types 16, 18) Major Product Offerings
7.7.4 WALVAX Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in Global (2018-2023)
7.7.5 WALVAX Key News & Latest Developments
8 Global Human Papillomavirus Vaccine (Types 16, 18) Production Capacity, Analysis
8.1 Global Human Papillomavirus Vaccine (Types 16, 18) Production Capacity, 2018-2032
8.2 Human Papillomavirus Vaccine (Types 16, 18) Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Papillomavirus Vaccine (Types 16, 18) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Papillomavirus Vaccine (Types 16, 18) Supply Chain Analysis
10.1 Human Papillomavirus Vaccine (Types 16, 18) Industry Value Chain
10.2 Human Papillomavirus Vaccine (Types 16, 18) Upstream Market
10.3 Human Papillomavirus Vaccine (Types 16, 18) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Papillomavirus Vaccine (Types 16, 18) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Papillomavirus Vaccine (Types 16, 18) in Global Market
Table 2. Top Human Papillomavirus Vaccine (Types 16, 18) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Papillomavirus Vaccine (Types 16, 18) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Share by Companies, 2018-2023
Table 5. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Companies, (K Units), 2018-2023
Table 6. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Product Type
Table 9. List of Global Tier 1 Human Papillomavirus Vaccine (Types 16, 18) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Papillomavirus Vaccine (Types 16, 18) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2018-2023
Table 15. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2024-2032
Table 16. By Application ? Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2018-2023
Table 20. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2024-2032
Table 21. By Region ? Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2018-2023
Table 25. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), 2024-2032
Table 26. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2018-2023
Table 29. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2024-2032
Table 30. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2024-2032
Table 34. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2024-2032
Table 38. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2018-2023
Table 41. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Sales, (K Units), 2024-2032
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 48. GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 52. Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 56. Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. INNOVAX Company Summary
Table 59. INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 60. INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. INNOVAX Key News & Latest Developments
Table 62. ZSSW Company Summary
Table 63. ZSSW Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 64. ZSSW Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. ZSSW Key News & Latest Developments
Table 66. HUMANWELL HEALTHCARE Company Summary
Table 67. HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 68. HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. HUMANWELL HEALTHCARE Key News & Latest Developments
Table 70. WALVAX Company Summary
Table 71. WALVAX Human Papillomavirus Vaccine (Types 16, 18) Product Offerings
Table 72. WALVAX Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. WALVAX Key News & Latest Developments
Table 74. Human Papillomavirus Vaccine (Types 16, 18) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Human Papillomavirus Vaccine (Types 16, 18) Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Human Papillomavirus Vaccine (Types 16, 18) Production by Region, 2018-2023 (K Units)
Table 77. Global Human Papillomavirus Vaccine (Types 16, 18) Production by Region, 2024-2032 (K Units)
Table 78. Human Papillomavirus Vaccine (Types 16, 18) Market Opportunities & Trends in Global Market
Table 79. Human Papillomavirus Vaccine (Types 16, 18) Market Drivers in Global Market
Table 80. Human Papillomavirus Vaccine (Types 16, 18) Market Restraints in Global Market
Table 81. Human Papillomavirus Vaccine (Types 16, 18) Raw Materials
Table 82. Human Papillomavirus Vaccine (Types 16, 18) Raw Materials Suppliers in Global Market
Table 83. Typical Human Papillomavirus Vaccine (Types 16, 18) Downstream
Table 84. Human Papillomavirus Vaccine (Types 16, 18) Downstream Clients in Global Market
Table 85. Human Papillomavirus Vaccine (Types 16, 18) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Papillomavirus Vaccine (Types 16, 18) Segment by Type in 2022
Figure 2. Human Papillomavirus Vaccine (Types 16, 18) Segment by Application in 2022
Figure 3. Global Human Papillomavirus Vaccine (Types 16, 18) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Papillomavirus Vaccine (Types 16, 18) Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, 2018-2032 (US$, Mn)
Figure 7. Human Papillomavirus Vaccine (Types 16, 18) Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Papillomavirus Vaccine (Types 16, 18) Revenue in 2022
Figure 9. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 11. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 12. By Type - Global Human Papillomavirus Vaccine (Types 16, 18) Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 15. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 16. By Application - Global Human Papillomavirus Vaccine (Types 16, 18) Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 20. By Region - Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 21. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 22. By Country - North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 23. US Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 28. Germany Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 29. France Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 37. China Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 41. India Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 43. By Country - South America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 44. Brazil Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share, 2018-2032
Figure 48. Turkey Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Human Papillomavirus Vaccine (Types 16, 18) Revenue, (US$, Mn), 2018-2032
Figure 52. Global Human Papillomavirus Vaccine (Types 16, 18) Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Human Papillomavirus Vaccine (Types 16, 18) by Region, 2022 VS 2032
Figure 54. Human Papillomavirus Vaccine (Types 16, 18) Industry Value Chain
Figure 55. Marketing Channels
